טוען...
Access to benznidazole for Chagas disease in the United States—Cautious optimism?
Drugs for neglected tropical diseases (NTD) are being excessively priced in the United States. Benznidazole, the first-line drug for Chagas disease, may become approved by the Food and Drug Administration (FDA) and manufactured by a private company in the US, thus placing it at risk of similar prici...
שמור ב:
| הוצא לאור ב: | PLoS Negl Trop Dis |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5598921/ https://ncbi.nlm.nih.gov/pubmed/28910299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0005794 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|